GSA Capital Partners’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-66,558
| Closed | -$235K | – | 1607 |
|
|
2020
Q4 | $235K | Buy |
+66,558
| New | +$235K | 0.04% | 894 |
|
|
2020
Q1 | – | Sell |
-6,647
| Closed | -$86K | – | 1685 |
|
|
2019
Q4 | $86K | Sell |
6,647
-13,696
| -67% | -$177K | 0.01% | 1348 |
|
|
2019
Q3 | $214K | Buy |
20,343
+6,666
| +49% | +$70.1K | 0.03% | 1141 |
|
|
2019
Q2 | $233K | Buy |
+13,677
| New | +$233K | 0.03% | 1163 |
|